WCG Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.79M Buy
+22,721
New +$8.43M 0.21% 114
2025
Q3
– Sell
-10,276
Closed -$4M – 341
2025
Q2
$4M Buy
+10,276
New +$4.13M 0.26% 100
2022
Q4
– Sell
-5,875
Closed -$2.84M – 188
2022
Q3
$2.84M Buy
5,875
+169
+3% +$80.9K 0.38% 59
2022
Q2
$2.75M Buy
+5,706
New +$2.82M 0.38% 61

Other funds holding ELV

WCG Wealth Advisors's ELV Position: Q2 2026 in Review

WCG Wealth Advisors opened a new position in Elevance Health (ELV) in Q2 2026: 22,721 shares worth $8.79M. The stake represents 0.21% of the portfolio and ranks #114 among its holdings. This is a return to the name: WCG Wealth Advisors previously reported a position in ELV as recently as Q2 2025.

WCG Wealth Advisors first reported a position in ELV in Q2 2022 and has held it in 4 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • WCG Wealth Advisors held 22,721 shares of Elevance Health worth $8.79M as of Q2 2026.
  • Elevance Health was a new WCG Wealth Advisors position in Q2 2026.
  • Elevance Health made up 0.21% of WCG Wealth Advisors's portfolio in Q2 2026, its #114 holding.
  • WCG Wealth Advisors first reported a position in Elevance Health in Q2 2022 and has held it in 4 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on WCG Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.